Mealtime fast ‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes

ConclusionFast ‐acting insulin aspart may hold promise as a more effective treatment compared with insulin aspart for controlling PPG in people with insulin‐resistant Type 2 diabetes.This article is protected by copyright. All rights reserved.

Source: Diabetic Medicine - November 22, 2018 Category: Endocrinology Authors: K. Bowering, J. Harvey, J. W. Kolaczynski, J. W. Snyder, B. W. Bode Tags: Short Report Source Type: research